Trials / Completed
CompletedNCT00214994
Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.
A 12-Month, Open-Label, Flexible-Dosage Study to Evaluate the Safety and Efficacy of GABITRIL Treatment (up to 16 mg/Day) in Adults With Generalized Anxiety Disorder.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Cephalon · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
A 12-Month, Open-Label, Flexible-Dosage Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults with Generalized Anxiety Disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gabitril |
Timeline
- Start date
- 2005-01-01
- Completion
- 2006-12-01
- First posted
- 2005-09-22
- Last updated
- 2014-05-09
Locations
93 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00214994. Inclusion in this directory is not an endorsement.